Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic profiling of dermatomyositis lesions.

ABSTRACT: The microarray experiment was employed to evaluate the gene expressions in skin lesions of dermatomyositis and healthy controls.

ORGANISM(S): Homo sapiens

PROVIDER: GSE142807 | GEO | 2020/04/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Transcriptomic profiling of LP lesions, hypertrophic LP (HLP) lesions, and healthy controls

Project description:The microarray experiment was employed to evaluate the gene expressions in skin lesions of LP, hypertrophic LP (HLP), and healthy controls.

2020-01-01 | GSE130403 | GEO

Transcriptomic profiling of dermatomyositis lesions.

Project description:Transcriptomic profiling of dermatomyositis lesions.

| PRJNA598373 | ENA

Transcriptomic profiling of Pityriasis Rubra Pilaris (PRP) and Psoriasis

Project description:The microarray experiment was employed to evaluate the gene expressions in skin lesions of PRP and psoriasis.

2021-09-30 | GSE183134 | GEO

Dermatomyositis skin transcriptomic signature

Project description:Dermatomyositis skin transcriptomic signature

| PRJNA527138 | ENA

Dermatomyositis skin transcriptomic signature

Project description:Dermatomyositis is a cutaneous and muscular auto-immune condition associated with specific autoantibodies. MDA5 antibody-associated DM has higher mortality. We demonstrate here for the first time using skin microarray analysis that MDA5+ DM is associated with a greater type I interferon skin signature than MDA5- DM, mainly involving the IFN- κ member produced by skin keratinocytes

2019-10-27 | GSE128314 | GEO

Transcriptomic profiling of DLE/SCLE/ACLE

Project description:The microarray experiment was employed to evaluate the gene expressions in cutaneous lupus

2021-11-16 | GSE184989 | GEO

Gene Expression Analysis of Dermatomyositis Skin

Project description:The purpose of this study was to use global gene expression analysis to determine major functional pathways and genes dysregulated in the skin of active rashes of dermatomyositis patients. These data will be used to help assign a diagnosis to skin biopsies from patients with rashes that are not clearly dermatomyositis. In addition, we will correlate gene expression changes with specific histopathologic changes in skin biopsies that are taken adjacent to those analyzed for gene expression analysis. Finally, these data will be used to search for genes and pathways that are associated with clinical outcomes and autoantibody status in this cohort of patients.

2013-04-20 | GSE46239 | GEO